116 related articles for article (PubMed ID: 10083474)
1. Inhibition of thromboxane A2 synthesis by OKY-046 attenuates ischemia and reperfusion injury of the liver.
Iida J; Shimamura T; Suzuki T; Jin MB; Taniguchi M; Fukai M; Yokota R; Horiuchi H; Magata S; Kishida A; Furukawa H; Todo S
Transplant Proc; 1999; 31(1-2):1061-2. PubMed ID: 10083474
[No Abstract] [Full Text] [Related]
2. The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice.
Takahashi T
Surg Today; 1996; 26(1):15-20. PubMed ID: 8680115
[TBL] [Abstract][Full Text] [Related]
3. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury.
Isozaki H; Okajima K; Hara H; Kobayashi M
Surg Today; 1994; 24(5):435-40. PubMed ID: 8054815
[TBL] [Abstract][Full Text] [Related]
4. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
[TBL] [Abstract][Full Text] [Related]
5. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats.
Tanaka M; Natori M; Ishimoto H; Miyakoshi K; Miyazaki T; Kobayashi T; Yoshimura Y
Biol Neonate; 1997; 72(3):181-6. PubMed ID: 9303217
[TBL] [Abstract][Full Text] [Related]
6. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.
Kobayashi T; Esato K; Morita N; Noshima NS
Int Surg; 1996; 81(2):115-8. PubMed ID: 8912073
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide enhancement attenuates ischemia and reperfusion injury of canine livers.
Shimamura T; Jin MB; Suzuki T; Iida J; Kishida A; Furukawa H; Todo S
Transplant Proc; 1999; 31(1-2):1065-7. PubMed ID: 10083476
[No Abstract] [Full Text] [Related]
9. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation.
Ishine N; Yagi T; Ishikawa T; Sasaki H; Nakagawa K; Tanaka N
Transplant Proc; 1997; 29(1-2):378-81. PubMed ID: 9123045
[No Abstract] [Full Text] [Related]
10. Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation.
Soejima Y; Yanaga K; Nisizaki T; Yoshizumi T; Uchiyama H; Sugimachi K
Surgery; 1998 Jan; 123(1):67-72. PubMed ID: 9457225
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective cyclooxygenase inhibitors on ischemia/reperfusion-induced hepatic microcirculatory dysfunction in mice.
Ito Y; Katagiri H; Ishii K; Kakita A; Hayashi I; Majima M
Eur Surg Res; 2003; 35(5):408-16. PubMed ID: 12928598
[TBL] [Abstract][Full Text] [Related]
12. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
Ogawa K; Sakai K; Ito T; Watanabe J; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():371-6. PubMed ID: 6221548
[No Abstract] [Full Text] [Related]
13. Thromboxane A2 in preservation-reperfusion injury: the effect of thromboxane A2 synthetase inhibitor.
Suehiro T; Yanaga K; Itasaka H; Kishikawa K; Shirbe K; Shimada M; Sugimachi K
J Surg Res; 1996 May; 62(2):216-23. PubMed ID: 8632642
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of TXA synthesis with OKY-046 improves liver preservation by prolonged hypothermic machine perfusion in rats.
Xu H; Lee CY; Clemens MG; Zhang JX
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e212-20. PubMed ID: 17645480
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of the thromboxane A2 receptor antagonist ONO 3708 on ischemia-reperfusion injury in the dog liver.
Hanazaki K; Kuroda T; Haba Y; Shiohara E; Kajikawa S; Iida F
Surgery; 1994 Nov; 116(5):896-903. PubMed ID: 7940195
[TBL] [Abstract][Full Text] [Related]
16. Involvement of thromboxane A2-thromboxane A2 receptor system of the hepatic sinusoid in pathogenesis of cold preservation/reperfusion injury in the rat liver graft.
Ishiguro S; Arii S; Monden K; Fujita S; Nakamura T; Niwano M; Harada T; Ushikubi F; Narumiya S; Imamura M
Transplantation; 1995 Apr; 59(7):957-61. PubMed ID: 7709455
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion.
Austin JC; Berrizbeitia LD; Schoen FJ; Kauffman RP; Hechtman HB; Cohn LH
Am Heart J; 1988 Mar; 115(3):505-9. PubMed ID: 3344655
[TBL] [Abstract][Full Text] [Related]
18. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thromboxane A2 activity during warm ischemia of the liver.
Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K
J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950
[TBL] [Abstract][Full Text] [Related]
20. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs.
Ishihara Y; Uchida Y; Kitamura S
Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]